Table 2.
Association of LINC01224 Expression with Clinicopathological Characteristics of Patients with EOC
| Characteristics | LINC01224 Expression | P | |
|---|---|---|---|
| High (n = 32) | Low (n = 31) | ||
| Age, years | 0.616 | ||
| <50 | 13 | 15 | |
| ≥50 | 19 | 16 | |
| Tumor size, cm | 0.045* | ||
| <5 | 12 | 20 | |
| ≥5 | 20 | 11 | |
| Differentiation | 0.315 | ||
| Well | 15 | 19 | |
| Moderate and poor | 17 | 12 | |
| FIGO stage | 0.019* | ||
| I/II | 7 | 16 | |
| III/IV | 25 | 15 | |
| Histological subtype | 0.305 | ||
| Serous | 22 | 17 | |
| Non-serous | 10 | 14 | |
| Lymph node metastasis | 0.011* | ||
| No | 9 | 19 | |
| Yes | 23 | 12 | |
Note: *P < 0.05 by chi-square test.
Abbreviations: LINC01224, long intergenic non-protein coding RNA 1224; EOC, epithelial ovarian cancer.